CDKN2A and neoplasm: Detailed by a new study (2020), an overexpression of p16 in the epidermis demonstrates pro-proliferative and pro-tumorigenic effects, creating a tumor-initiating environment that is supportive of cells carrying an oncogenic mutation [88].